CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Option exercise 10b5-1 | +33,000 | $3.50 | $116K | 75,867 |
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Sale 10b5-1 | −33,000 | $240.09 | $7.9M | 42,867 |
| 2026-06-09 | Pizzie Nick Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −33,000 | 72,000 | ||
| 2026-06-08 | JEFFS ROGER Director | Option exercise | +1,429 | 58,939 | ||
| 2026-06-08 | JEFFS ROGER Director | Option exercise · Restricted Stock Units | −1,429 | 0 | ||
| 2026-06-08 | Saad Mark E Director | Option exercise | +1,429 | 11,431 | ||
| 2026-06-08 | Saad Mark E Director | Option exercise · Restricted Stock Units | −1,429 | 0 | ||
| 2026-06-08 | Mahony Susan Director | Option exercise 10b5-1 | +1,429 | 1,429 | ||
| 2026-06-08 | Mahony Susan Director | Option exercise · Restricted Stock Units 10b5-1 | −1,429 | 0 | ||
| 2026-06-08 | Coleman Mark Director | Option exercise 10b5-1 | +1,429 | 31,032 | ||
| 2026-06-08 | Coleman Mark Director | Option exercise · Restricted Stock Units 10b5-1 | −1,429 | 0 | ||
| 2026-06-05 | Coleman Mark Director | Grant or award · Restricted Stock Units | +1,721 | 1,721 | ||
| 2026-06-05 | Mahony Susan Director | Grant or award · Restricted Stock Units | +1,721 | 1,721 | ||
| 2026-06-05 | Saad Mark E Director | Grant or award · Restricted Stock Units | +1,721 | 1,721 | ||
| 2026-06-05 | JEFFS ROGER Director | Grant or award · Restricted Stock Units | +1,721 | 1,721 | ||
| 2026-06-02 | Coleman Mark Director | Sale 10b5-1 | −5,537 | $223.39 | $1.2M | 29,603 |
| 2026-06-01 | Coleman Mark Director | Sale 10b5-1 | −6,000 | $230.30 | $1.4M | 35,140 |
| 2026-05-29 | Coleman Mark Director | Sale 10b5-1 | −6,000 | $233.46 | $1.4M | 41,140 |
| 2026-05-05 | Jacobson Mark L. Chief Operating Officer | Option exercise 10b5-1 | +233 | $12.95 | $3K | 233 |
| 2026-05-05 | Jacobson Mark L. Chief Operating Officer | Sale 10b5-1 | −233 | $228.18 | $53K | 0 |
Page 2 of 22 · 422 trades